Please ensure Javascript is enabled for purposes of website accessibility

Why BioNTech Stock Is Jumping Today

By Keith Speights - Mar 30, 2021 at 11:39AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The biotech reported great fourth-quarter results.

What happened

Shares of BioNTech (BNTX -1.72%) were trading 6.9% higher as of 11:13 a.m. EDT on Tuesday. The German biotech announced its fourth-quarter and full-year 2020 results before the market opened.

So what

BioNTech reported quarterly revenue of 345.4 million euros, a huge increase from the 28 million euros it brought in during the prior-year period. It also achieved profitability for the first time as a publicly traded company.

Vaccine vials and a syringe next to stacks of cash

Image source: Getty Images.

COVID-19 vaccine BNT162b2 was, unsurprisingly, the difference-maker for BioNTech in Q4. The biotech splits net profits from sales of the vaccine equally with Pfizer in all markets except China. 

BioNTech's Q4 results included only a few weeks of sales of BNT162b2, though. The vaccine won its first authorization in the U.K. on Dec. 2. Over the next few weeks, BioNTech and Pfizer secured additional regulatory authorizations in the U.S. and in the European Union.

Now what

Investors might need to get used to seeing great quarterly results that send this biotech stock higher. BioNTech expects to generate revenue of around 9.8 billion euros from its current supply agreements. However, the company thinks that even more supply deals are coming, which will further boost its revenue.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

BioNTech SE Stock Quote
BioNTech SE
$157.06 (-1.72%) $-2.74
Pfizer Inc. Stock Quote
Pfizer Inc.
$50.40 (-1.83%) $0.94

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.